SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations

The use of monoclonal antibodies in children with certain conditions and at high risk for severe COVID-19 has been approved by the US Food and Drug Administration under the Emergency Use Authorization mechanism of the Federal Food, Drug, and Cosmetic Act. No data on the tolerability or efficacy of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfe, Ian D., Patel, Sameer J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
COVID Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101787/
https://www.ncbi.nlm.nih.gov/pubmed/34049725
http://dx.doi.org/10.1016/j.clinthera.2021.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101787/
https://www.ncbi.nlm.nih.gov/pubmed/34049725
http://dx.doi.org/10.1016/j.clinthera.2021.04.008

Ejemplares similares